Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $2.70 USD
Change Today +0.14 / 5.47%
Volume 1.9M
ARNA On Other Exchanges
As of 8:10 PM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jack Lief Ph.D.

Co-Founder, Chairman, Chief Executive Officer, President and Principal Financial Officer,Arena Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 15 board members in 4 different organizations across 7 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Jack Lief, Ph.D Co-founded Arena Pharmaceuticals, Inc. and has been its President and Chief Executive Officer since April 1997 and its Principal Financial Officer since July 10, 2015. Mr. Lief served as the Chief Financial Officer of Arena Pharmaceuticals Inc., since March 1, 2011. From 1995 to April 1997, he served as an Advisor and Consultant to numerous biopharmaceutical organizations. From 1989 to 1994, he served as the Senior Vice President of Corporate Development ...

Read Full Background

Corporate Headquarters*

6154 Nancy Ridge Drive
San Diego, California 92121

United States

Phone: 858-453-7200
Fax: 858-453-7210

Board Members Memberships*

Co-Founder, Chairman, Chief Executive Officer, President and Principal Financial Officer


Lehigh University
Rutgers, The State University of New Jersey

Other Affiliations*

Annual Compensation*

Total Annual Compensation$746,750

Stock Options*

Restricted Stock Awards$1,636,600
All Other Compensation$16,068
Exercised Options200,000
Exercised Options Value$421,374
Exercisable Options1,554,100
Exercisable Options Value$901,845
Unexercisable Options840,000
Unexercisable Options Value$771,000
Total Value of Options$2,094,219
Total Number of Options2,594,100

Total Compensation*

Total Annual Cash Compensation$1,146,274
Total Short Term Compensation$746,750
Other Long Term Compensation$1,652,668
Total Calculated Compensation$3,204,152
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ARNA:US $2.70 USD +0.14


Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma Inc.
Raul R. Rodriguez Chief Executive Officer, President, Director and Member of Finance Committee
Rigel Pharmaceuticals, Inc.
Rajesh C. Shrotriya M.D.Chairman and Chief Executive Officer
Spectrum Pharmaceuticals, Inc.
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
Michael A. Narachi M.S., M.B.A.Chief Executive Officer, President and Director
Orexigen Therapeutics, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ARENA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at